EVIDENCE FOR EOSINOPHIL ACTIVATION IN BRONCHIECTASIS UNRELATED TO CYSTIC-FIBROSIS AND BRONCHOPULMONARY ASPERGILLOSIS - DISCREPANCY BETWEEN BLOOD EOSINOPHIL COUNTS AND SERUM EOSINOPHIL CATIONIC PROTEIN-LEVELS
C. Kroegel et al., EVIDENCE FOR EOSINOPHIL ACTIVATION IN BRONCHIECTASIS UNRELATED TO CYSTIC-FIBROSIS AND BRONCHOPULMONARY ASPERGILLOSIS - DISCREPANCY BETWEEN BLOOD EOSINOPHIL COUNTS AND SERUM EOSINOPHIL CATIONIC PROTEIN-LEVELS, Thorax, 53(6), 1998, pp. 498-500
Background-Increased serum levels of eosinophil cationic protein (ECP)
have been detected in adolescent patients with cystic fibrosis. Howev
er, ECP concentrations in adult patients with bronchiectasis unrelated
to cystic fibrosis have not been studied. Methods-Eosinophil numbers
and serum concentrations of ECP were determined in 14 patients with kn
own or newly diagnosed bronchiectasis and compared with age and sex ma
tched patients with allergic bronchial asthma, chronic obstructive pul
monary disease (COPD), and controls in whom bronchiectasis or obstruct
ive pulmonary disease could be excluded. Results-Serum ECP levels were
significantly raised both in patients with bronchiectasis (median (ra
nge) 22.5 mu g/l (7-85)) and allergic asthma (35.0 mu g/l (7-128)) com
pared with the seu and age matched subjects suffering from COPD (6.7 m
u g/l (1.5-28); p<0.006) and non-obstructive normal controls (7.5 mu g
/l (3.5-19); p<0.003). In contrast, significantly increased peripheral
eosinophil numbers were observed in patients with bronchial asthma (3
05 x 10(6)/l; p<0.01) but not in those with bronchiectasis (10(2) x 10
(6)/l), COPD (117 x 10(6)/l), and healthy controls (101x 10(6)/l). Con
clusions-The discrepancy between eosinophil counts and eosinophil numb
ers in patients with bronchiectasis suggests that serum ECP levels may
be more relevant in assessing local eosinophil involvement than blood
eosinophil numbers.